# Study of AT-752 in Healthy Subjects

> **NCT04722627** · PHASE1 · COMPLETED · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Dengue

## Interventions

- **DRUG:** AT-752
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04722627
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2021-11-14
- **Final completion:** 2021-11-14
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722627, "Study of AT-752 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04722627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*